tm logo
LYELL
Live/Pending
FIFTH EXTENSION - GRANTED

granted

on 29 Oct 2024

Last Applicant/ Owned by

201 Haskins Way

South San Francisco

CA

94080

Serial Number

90689670 filed on 04th May 2021

Registration Number

N/A

Correspondent Address

Christina L. Martini

Christina L. Martini MCDERMOTT WILL & EMERY LLP

CHICAGO, IL 60606-0029

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LYELL

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientifi Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research; scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of cancer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Custom manufacture of pharmaceuticals


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 90689670

Mark Type

No Service Mark

Attorney Docket Number

No 111076-0038

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.02 -

Plain single line circles

26.01.20 -

Circles within a circle

26.01.21 -

Circles that are totally or partially shaded

Legal History


Show more

Status DateAction Taken
29th Oct 2024SOU EXTENSION 5 FILED
29th Oct 2024SOU EXTENSION 5 GRANTED
29th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Oct 2024SOU TEAS EXTENSION RECEIVED
30th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Apr 2024SOU EXTENSION 4 GRANTED
29th Apr 2024SOU EXTENSION 4 FILED
29th Apr 2024SOU TEAS EXTENSION RECEIVED
01st Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30th Oct 2023SOU EXTENSION 3 GRANTED